Protocol Design Featured Articles
-
Roche Diagnostics Guides New Alzheimer's Test Through Trials
2/12/2025
Roche Diagnostics’ Maria-Magdelena Patru, MD, PhD discusses their plasma test and how they’re approaching its clinical trials.
-
How PDS Biotech Approached FDA Meetings For Its Phase 3 Cancer Trial
2/11/2025
PDS Biotech CMO Kirk Shepard reveals his team’s interactions with the FDA as it sought to begin its Phase 3 trial for the treatment of HPV-positive recurrent and/or metastatic head and neck squamous cell carcinoma.
-
Input Needed On Using AI To Create Lay Summaries Of Trial Results
2/7/2025
CISCRP is soliciting feedback from research professionals, patients, and advocacy groups on its "Considerations for Using AI to Create Lay Summaries of Trial Results" until Feb. 18.
-
Annual SCOPE Summit Serves Up A Similar But Satisfying Menu
2/7/2025
Executive editor Abby Proch sums up her second SCOPE Summit experience.
-
A Tool To Tackle The Risk Of Uninformative Trials
1/31/2025
Uninformative trials hinder progress in clinical practice, policy decisions, and further research. Fast Data Science developed a free risk tool to help pharma companies avoid them.
-
In Clinical Research, Every Day Is Groundhog Day
1/30/2025
Rather than proffer some New Year's predictions, Paul Ivsin looks at clinical research through the lens of Groundhog Day and the tradition of reinventing the same thing over and over again.
-
Biopharma R&D Faces Productivity And Attrition Challenges In 2025
1/29/2025
Evaluate VP of Thought Leadership Daniel Chancellor discusses trends for 2025 as the surge in R&D, coupled with rapidly evolving industry dynamics, presents a productivity and attrition challenge for the industry.
-
Biohaven Refines Epilepsy Trial Design With Patient-Centric Focus
1/17/2025
Medical director and clinical lead Jason T. Lerner, MD discusses Biohaven's patient-centric approach to its pediatric epilepsy clinical trials, from reducing visit frequency to offering virtual visits and more.
-
Bridging Continents For Clinical Development
1/16/2025
By leveraging Australia's ecosystem as a launchpad, organizations managing both early-stage and advanced development can enhance trial quality and position themselves for success.
-
Takeda Taps AI Partner To Improve Patient Selection, Clinical Assessments, And Treatment Pathways For IBD
1/10/2025
Takeda's Vijay Yajnik, MD, Ph.D. describes the company's partnership with an AI/ML vendor to improve endoscopic assessments in inflammatory bowel disease (IBD) research.